Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer

PURPOSE: This phase II trial first describes the combination chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) for pretreated advanced gastric cancer (AGC) patients. METHODS: Patients who had previously been treated with greater than or equal to one regimen were enrolled. They received S-...

Descripción completa

Detalles Bibliográficos
Autores principales: Chon, Hong Jae, Rha, Sun Young, Park, Hyung Soon, Shin, Sang Joon, Kim, Hyo Song, Roh, Jae Kyung, Noh, Sung Hoon, Chung, Hyun Cheol, Jeung, Hei-Cheul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180611/
https://www.ncbi.nlm.nih.gov/pubmed/21327684
http://dx.doi.org/10.1007/s00280-011-1560-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180611/
https://www.ncbi.nlm.nih.gov/pubmed/21327684
http://dx.doi.org/10.1007/s00280-011-1560-9

Ejemplares similares